Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DG.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.56NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KP.2.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XDP.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HN.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KL.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.24.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.2.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.1.5.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HE.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JM.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HV.1.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GP.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.3.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBVNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.62NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.3.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.110.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.23 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.9 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.74 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.621.1 (Mu)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17723.5South Korea
BQ.1.1.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CK.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.34NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CJ.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.6.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.7.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.3.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FA.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.464NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.234NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.231NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.243NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.517NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.291NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used